Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 424
Selected: 0
NCT IDTitle
NCT01658527TAK-700 in Castration Resistant Prostate Cancer
NCT00438737Cetuximab, Leucovorin, Oxaliplatin, and Fluorouracil With or Without Bevacizumab in Treating Patients With Resectable Liver Metastases From Colorectal Cancer
NCT00085228Docetaxel With or Without Oblimersen in Treating Patients With Hormone-Refractory Adenocarcinoma (Cancer) of the Prostate
NCT00068757Lonafarnib, Trastuzumab, and Paclitaxel in Treating Patients With HER2/Neu-Overexpressing Stage IIIB, Stage IIIC, or Stage IV Breast Cancer
NCT00956072Imatinib Mesylate With or Without Surgery in Treating Patients With Metastatic Gastrointestinal Stromal Tumor That is Responding to Imatinib Mesylate
NCT00006477Mistletoe Lectin in Treating Patients With Refractory Advanced Solid Tumors
NCT00002972Paclitaxel in Treating Patients With Lung Cancer
NCT02172872"InDACtion" vs "3+7" Induction in AML
NCT06326190177Lu-DOTATATE for Recurrent Meningioma
NCT04685616Brentuximab Vedotin in Early Stage Hodgkin Lymphoma
NCT00086866Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed With Surgery
NCT06783348Radiopharmaceutical Treatment of Advanced Kidney Cancer
NCT00027677Halofuginone Hydrobromide in Treating Patients With Progressive Advanced Solid Tumors
NCT03590171International Study for Treatment of High Risk Childhood Relapsed ALL 2010
NCT01324063A Randomized Phase III Study of Intensive Consolidation With High Dose Cytosine Arabinoside in Acute Myelogenous Leukemia (AML-8B)
NCT00005980Comparison of Two Regimens of Liposomal Doxorubicin in Treating Women With Metastatic Breast Cancer
NCT05815927Pembrolizumab and Radiotherapy for Oligometastatic Head and Neck Cancer
NCT00006354Mistletoe Lectin in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy
NCT03818503E²-RADIatE: EORTC-ESTRO RADiotherapy InfrAstrucTure for Europe
NCT01208064Pazopanib Hydrochloride or a Placebo in Treating Patients With Non-Small Cell Lung Cancer Who Have Received First-Line Chemotherapy
NCT00003152Chemotherapy Plus Interferon Alfa Alone or With Radiation Therapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Follicular Non-Hodgkin's Lymphoma
NCT02808247Ph II Nintedanib vs. Ifosfamide in Soft Tissue Sarcoma
NCT00004128Combination Chemotherapy, Interleukin-2, and Peripheral Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia
NCT00002511Radiation Therapy Compared With No Further Treatment Following Surgery in Treating Patients With Prostate Cancer
NCT00077116Idarubicin, Cytarabine, and Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome
NCT04995575Dissecting the Pathways of Therapy Resistance in Early Breast Cancer
NCT00052312Doxorubicin and Cisplatin With or Without Paclitaxel in Treating Patients With Locally Advanced, Metastatic, and/or Relapsed Endometrial Cancer
NCT00003981E7070 in Treating Patients With Solid Tumors
NCT01905592A Phase III Trial of Niraparib Versus Physician's Choice in HER2 Negative, Germline BRCA Mutation-positive Breast Cancer Patients
NCT02834884SPECTA: Screening Cancer Patients for Efficient Clinical Trial Access
NCT00039364Imatinib Mesylate in Treating Patients With Gliomas
NCT04218825REACH: Study to Determine the Aetiology of Chlormethine Gel Induced-skin Drug Reaction in Early Stage Mycosis Fungoides Cutaneous T Cell Lymphoma (MF-CTCL)
NCT00043004Chemotherapy and Bevacizumab With or Without Radiofrequency Ablation in Treating Unresectable Liver Metastases in Patients With Colorectal Cancer
NCT06310369Radiotherapy for BCG-unresponsive Non-muscle-invasive Carcinoma in Situ (CIS) Bladder Cancer
NCT00005061Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Solid Tumors
NCT00003640Transurethral Resection and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
NCT03563040Study of Photopheresis in the Treatment of Erythrodermic MF and SS
NCT00002903Docetaxel in Treating Patients With Recurrent or Refractory Germ Cell Cancer
NCT04498767Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)
NCT00053807Interleukin-2, Interferon Alfa, and Fluorouracil Compared With Observation in Treating Patients Who Have Undergone Surgery for Kidney Cancer
NCT00039208Combination Chemotherapy in Treating Patients With Colorectal Cancer
NCT00003031Comparison of Voriconazole and Amphotericin B in Treating Patients With Aspergillosis
NCT00017498Gemcitabine in Treating Patients With Recurrent or Metastatic Adenoid Cystic Cancer of the Head and Neck
NCT00626990Phase III Trial of Anaplastic Glioma Without 1p/19q Loss of Heterozygosity (LOH)
NCT00003803Chemotherapy Plus Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Cannot Be Surgically Removed
NCT06978062Peri-operative Treatment of Resectable Gastroesophageal Cancer Using Bemarituzumab (BEMA) Plus Perioperative Treatment
NCT02580994Pembrolizumab in Untreated Extensive SCLC
NCT00017095Biomarker (p53 Gene) Analysis and Combination Chemotherapy Followed by Radiation Therapy and Surgery in Treating Women With Large Operable or Locally Advanced or Inflammatory Breast Cancer
NCT00110123Intravenous or Hepatic Arterial Infusion of Fotemustine in Treating Patients With Unresectable Liver Metastases From Eye Melanoma
NCT00081237OSI-7904L and Oxaliplatin in Treating Patients With Refractory or Recurrent Advanced Colorectal Cancer